Form 8-K - Current report:
SEC Accession No. 0000950170-25-106915
Filing Date
2025-08-12
Accepted
2025-08-12 07:15:31
Documents
12
Period of Report
2025-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcrx-20250812.htm   iXBRL 8-K 48743
2 EX-99.1 tcrx-ex99_1.htm EX-99.1 134077
3 GRAPHIC img207367504_0.jpg GRAPHIC 85034
  Complete submission text file 0000950170-25-106915.txt   424908

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tcrx-20250812.xsd EX-101.SCH 30851
14 EXTRACTED XBRL INSTANCE DOCUMENT tcrx-20250812_htm.xml XML 4708
Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)